MYC and cancer: Among the 12 proteins verified by IP and RNA pull‐down, c‐Myc, which has been reported to be closely correlated with mutp53 in cancers,[26] was selected as the downstream cotarget of both HDAC1 and circCFL1, and the peptide sequence of c‐Myc identified by IP is shown in Figure 5C.